Better outcomes through MMC at Cambridge Cancer Research Hospital
In partnership with the Trust and project team, Akerlof developed an MMC strategy at RIBA Stage 2 and 3 for the new Cambridge Cancer Research Hospital (CCRH). Part of the New Hospitals Programme (NHP), CCRH is planned to be a world-class facility that brings together clinical and research expertise.
What we did
In collaboration with AECOM and NBBJ, we aided the Trust in its ambition to create better healthcare infrastructure, as quickly as possible, in detecting cancer earlier, treating it more precisely and saving more lives.
By embedding Modern Methods of Construction (MMC) and platform principles at the earliest opportunity, we helped the Trust further its ambitions to create a world-class facility.
The MMC strategy applies an intelligent approach focused to deliver value for the client and stakeholders. Translating themes of standardisation, DfMA, manufacture, digitisation and industrialisation into actionable activity, we educated and empowered the project team to adopt of MMC, where it delivers value.
- Raised the awareness and understanding of MMC within the project team
- Delivered the business case requirements in respect of MMC
- Fostered an increase in adoption of MMC, thereby enhancing outcomes such as time, cost, risk, sustainability and social value
- Received commendations from NHP Technical Advisors
Don't just take our word for it...
NHP Technical Advisors